These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 66306)
1. Orientation of the oxygen atom at C-6 as a determinant of agonistic activity in the oxymorphone series. Ronai AZ; Foldes FF; Hahn EF; Fishman J J Pharmacol Exp Ther; 1977 Mar; 200(3):496-500. PubMed ID: 66306 [TBL] [Abstract][Full Text] [Related]
2. 7-spirobenzocyclohexyl derivatives of naltrexone, oxymorphone, and hydromorphone as selective opioid receptor ligands. Fang X; Larson DL; Portoghese PS J Med Chem; 1997 Sep; 40(19):3064-70. PubMed ID: 9301669 [TBL] [Abstract][Full Text] [Related]
3. Irreversible opiate agonists and antagonists. II. Evidence against a bivalent mechanism of action for opiate azines and diacylhydrazones. Hahn EF; Nishimura S; Goodman RR; Pasternak GW J Pharmacol Exp Ther; 1985 Dec; 235(3):839-45. PubMed ID: 2416909 [TBL] [Abstract][Full Text] [Related]
6. Irreversible opiate agonists and antagonists. III. Phenylhydrazone derivatives of naloxone and oxymorphone. Hahn EF; Itzhak Y; Nishimura S; Johnson N; Pasternak GW J Pharmacol Exp Ther; 1985 Dec; 235(3):846-50. PubMed ID: 2416910 [TBL] [Abstract][Full Text] [Related]
7. Diastereomeric 6-desoxy-6-spiro-alpha-methylene-gamma-butyrolactone derivatives of naltrexone and oxymorphone. Selective irreversible inhibition of naltrexone binding in an opioid receptor preparation by a conformationally restricted michael acceptor ligand. Koolpe GA; Nelson WL; Gioannini TL; Angel L; Simon EJ J Med Chem; 1984 Dec; 27(12):1718-23. PubMed ID: 6209395 [TBL] [Abstract][Full Text] [Related]
8. The structure-action relationship and kinetics of some naloxone and naltrexone derivatives. Vizi ES; Foldes FF; Rich J; Knoll J Pharmacology; 1976; 14(1):76-85. PubMed ID: 959310 [TBL] [Abstract][Full Text] [Related]
9. Identification of opioid ligands possessing mixed micro agonist/delta antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone [correction of hydropmorphone]. Ananthan S; Khare NK; Saini SK; Seitz LE; Bartlett JL; Davis P; Dersch CM; Porreca F; Rothman RB; Bilsky EJ J Med Chem; 2004 Mar; 47(6):1400-12. PubMed ID: 14998329 [TBL] [Abstract][Full Text] [Related]
10. Opioid agonists and antagonists. 6-Desoxy-6-substituted lactone, epoxide, and glycidate ester derivatives of naltrexone and oxymorphone. Koolpe GA; Nelson WL; Gioannini TL; Angel L; Appelmans N; Simon EJ J Med Chem; 1985 Jul; 28(7):949-57. PubMed ID: 2409280 [TBL] [Abstract][Full Text] [Related]
11. Agonist-antagonist properties of fluorescent opioid probes in the guinea-pig myenteric plexus-longitudinal muscle preparation. Koman A; Einarsson M; Terenius L Naunyn Schmiedebergs Arch Pharmacol; 1985 Dec; 331(4):355-8. PubMed ID: 2419770 [TBL] [Abstract][Full Text] [Related]
12. The irreversible narcotic antagonistic and reversible agonistic properties of the fumaramate methyl ester derivative of naltrexone. Takemori AE; Larson DL; Portoghese PS Eur J Pharmacol; 1981 Apr; 70(4):445-51. PubMed ID: 6263637 [TBL] [Abstract][Full Text] [Related]
14. Morphine analgesia after intrathecal administration of a narcotic agonist, chloroxymorphamine and antagonist, chlornaltrexamine. Larson AA; Armstrong MJ Eur J Pharmacol; 1980 Nov; 68(1):25-31. PubMed ID: 6161013 [No Abstract] [Full Text] [Related]
15. Chloroacryloyl amides and alpha-methylenelactones from naltrexone, oxymorphone and fentanyl. Archer S; Michael J; Michael M; Simon EJ; Abdelhamid EM; Nelson WL; Koolpe GA Neuropeptides; 1985 Feb; 5(4-6):395-8. PubMed ID: 2582304 [TBL] [Abstract][Full Text] [Related]
16. Metabolic reduction of naltrexone. I. Synthesis, separation and characterization of naloxone and naltrexone reduction products and qualitative assay of urine and bile following administration of naltrexone, alpha-naltrexol, or beta-naltrexol. Malspeis L; Bathala MS; Ludden TM; Bhat HB; Frank SG; Sokoloski TD; Morrison BE; Reuning RH Res Commun Chem Pathol Pharmacol; 1975 Sep; 12(1):43-65. PubMed ID: 810832 [TBL] [Abstract][Full Text] [Related]
18. Irreversible opiate agonists and antagonists: the 14-hydroxydihydromorphinone azines. Hahn EF; Carroll-Buatti M; Pasternak GW J Neurosci; 1982 May; 2(5):572-6. PubMed ID: 6176696 [TBL] [Abstract][Full Text] [Related]
19. Oxymorphone metabolism and urinary excretion in human, rat, guinea pig, rabbit, and dog. Cone EJ; Darwin WD; Buchwald WF; Gorodetzky CW Drug Metab Dispos; 1983; 11(5):446-50. PubMed ID: 6194952 [TBL] [Abstract][Full Text] [Related]
20. Use of the novel irreversible opiate antagonist, beta-chlornaltrexamine, in the estimation of the normorphine affinity constant in naive and morphine tolerant guinea-pig ilea. Porreca F; Burks TF Proc West Pharmacol Soc; 1983; 26():295-7. PubMed ID: 6684293 [No Abstract] [Full Text] [Related] [Next] [New Search]